Paper2390468
Thyroiditis after treatment with interleukin-2 and interferon alpha-2a.
Pichert G and 5 others. Br J Cancer, 1990. Cited by 77 papers, by iCite.
Cite this record
ConductScience Library. Thyroiditis after treatment with interleukin-2 and interferon alpha-2a. Papers, record 2390468. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2390468
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferon Type I | Major topic |
| Interferon-alpha | Major topic |
| Interleukin-2 | Major topic |
| Thyroiditis | Major topic |
| Adult | |
| Carcinoma, Renal Cell | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Immunity, Cellular | |
| Immunohistochemistry | |
| Interferon alpha-2 | |
| Kidney Neoplasms | |
| Male | |
| Melanoma | |
| Middle Aged | |
| Prospective Studies | |
| Recombinant Proteins | |
| Thyroid Gland | |
| Thyrotropin |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 371875 | Goitrous autoimmune thyroiditis (Hashimoto's disease). | Clin Endocrinol Metab | 1979 | https://conductscience.org/library/papers/371875 | PubMed |
| 2 | 2502555 | Influence of tumor necrosis factor-alpha on the modulation by interferon-gamma of HLA class II molecules in human thyroid cells and its effect on interferon-gamma binding. | J Clin Endocrinol Metab | 1989 | https://conductscience.org/library/papers/2502555 | PubMed |
| 3 | 6138647 | Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. | Lancet | 1983 | https://conductscience.org/library/papers/6138647 | PubMed |
| 4 | 3930110 | Interferon-gamma induces HLA-DR expression by thyroid epithelium. | Clin Exp Immunol | 1985 | https://conductscience.org/library/papers/3930110 | PubMed |
| 5 | 2944910 | Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. | J Clin Endocrinol Metab | 1986 | https://conductscience.org/library/papers/2944910 | PubMed |
| 6 | 3493432 | A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. | N Engl J Med | 1987 | https://conductscience.org/library/papers/3493432 | PubMed |
| 7 | 3495802 | Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3495802 | PubMed |
| 8 | 3115656 | Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis. | Clin Exp Immunol | 1987 | https://conductscience.org/library/papers/3115656 | PubMed |
| 9 | 3499823 | The immunopathology of sequential tumor biopsies in patients treated with interleukin-2. Correlation of response with T-cell infiltration and HLA-DR expression. | Am J Pathol | 1987 | https://conductscience.org/library/papers/3499823 | PubMed |
| 10 | 3258138 | Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial. | Ann Intern Med | 1988 | https://conductscience.org/library/papers/3258138 | PubMed |
| 11 | 2452856 | Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis. | J Exp Med | 1988 | https://conductscience.org/library/papers/2452856 | PubMed |
| 12 | 3286117 | Autoimmune thyroid disease: immunological, pathological, and clinical aspects. | Crit Rev Clin Lab Sci | 1988 | https://conductscience.org/library/papers/3286117 | PubMed |
| 13 | 3259674 | Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. | N Engl J Med | 1988 | https://conductscience.org/library/papers/3259674 | PubMed |
| 14 | 3139285 | Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells. | Cancer Res | 1988 | https://conductscience.org/library/papers/3139285 | PubMed |
| 15 | 2460358 | An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer. | Eur J Cancer Clin Oncol | 1988 | https://conductscience.org/library/papers/2460358 | PubMed |
| 16 | 2647913 | A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma. | J Clin Oncol | 1989 | https://conductscience.org/library/papers/2647913 | PubMed |
| 17 | 2785167 | Hypothyroidism after interleukin-2 therapy. | J Clin Oncol | 1989 | https://conductscience.org/library/papers/2785167 | PubMed |
| 18 | 2787749 | Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors. | Eur J Cancer Clin Oncol | 1989 | https://conductscience.org/library/papers/2787749 | PubMed |
| 19 | 6138646 | Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. | Lancet | 1983 | https://conductscience.org/library/papers/6138646 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42891082 | Immunocytokines in cancer: a safety perspective. | Front Immunol | 2026 | https://conductscience.org/library/papers/42891082 | PubMed |
| 25294906 | MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/25294906 | PubMed |
| 22010182 | Thyroid dysfunction from antineoplastic agents. | J Natl Cancer Inst | 2011 | https://conductscience.org/library/papers/22010182 | PubMed |
| 17372828 | A case of hyperthyroidy developing in "pegylated-interferon" therapy. | Dig Dis Sci | 2007 | https://conductscience.org/library/papers/17372828 | PubMed |
| 11051216 | Drug-induced rheumatic disorders: incidence, prevention and management. | Drug Saf | 2000 | https://conductscience.org/library/papers/11051216 | PubMed |
| 9972674 | Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis. | J Endocrinol Invest | 1998 | https://conductscience.org/library/papers/9972674 | PubMed |
| 8264254 | Low dose cyclophosphamide, alpha-interferon and continuous infusions of interleukin-2 in advanced renal cell carcinoma. | Med Oncol Tumor Pharmacother | 1993 | https://conductscience.org/library/papers/8264254 | PubMed |
| 8061797 | Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon. | J Gastroenterol | 1994 | https://conductscience.org/library/papers/8061797 | PubMed |
| 7824050 | Effects of type I-interferons on human thyroid epithelial cells derived from normal and tumour tissue. | Naunyn Schmiedebergs Arch Pharmacol | 1994 | https://conductscience.org/library/papers/7824050 | PubMed |
| 7711430 | Suppressed thyroid-stimulating hormone secretion in patients treated with interleukin-2 and interferon-alpha 2b for metastatic melanoma. | Clin Investig | 1994 | https://conductscience.org/library/papers/7711430 | PubMed |
| 7693434 | Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer. | Drugs | 1993 | https://conductscience.org/library/papers/7693434 | PubMed |
| 7516663 | Clinical toxicity of the interferons. | Drug Saf | 1994 | https://conductscience.org/library/papers/7516663 | PubMed |
| 1997108 | Clinical and immune modulatory effects of alternative weekly interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma and melanoma. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1997108 | PubMed |
| 1931616 | Thyroid dysfunction can predict response to immunotherapy with interleukin-2 and interferon-2 alpha. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1931616 | PubMed |
| 1418698 | Clinical toxicity of interleukin-2. | Drug Saf | 1992 | https://conductscience.org/library/papers/1418698 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FCGR3A | 2214 | PubTator's text mining | https://conductscience.org/library/genes/2214 | NCBI Gene |
| IFNA2 | 3440 | PubTator's text mining | https://conductscience.org/library/genes/3440 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| TG | 7038 | PubTator's text mining | https://conductscience.org/library/genes/7038 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2390468
GET https://conductscience.org/api/papers/v1/2390468/authors